+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
SMT

Sahajanand Medical Technologies Share Price

₹533.95 +29.3 (5.81%)

13 Nov, 2026 3:56 PM (IST)

Sahajanand Medical Technologies live price: ₹533.95. It opened at ₹505 vs previous close ₹505; intraday high/low: ₹544/₹492.

Sahajanand Medical Technologies Performance

  • Today's Low
  • ₹492
  • Today's High
  • ₹544
  • 52 Week Low
  • ₹347
  • 52 Week High
  • ₹566
  • Open Price₹505
  • Previous Close₹505
  • Volume2,032,151
  • 50 DMA-
  • 100 DMA-
  • 200 DMA-

Sahajanand Medical Technologies Chart

Investment Returns

  • Over 1 Month + 55.22%
  • Over 3 Month + 55.22%
  • Over 6 Month + 55.22%
  • Over 1 Year + 55.22%

Smart Investing Starts Here Start SIP with Sahajanand Medical Technologies for Steady Growth!

Invest Now

Sahajanand Medical Technologies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 5,427
  • P/B Ratio
  • 7.6
  • Average True Range
  • 45.6
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 71.91
  • MFI
  • 77.34

Latest Stock News Updates

Sahajanand Medical Technologies Ltd - 545001 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Schedule of Analyst/Investor Meet

Sahajanand Medical Technologies Ltd - 545001 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of Earnings Call for Q2 & H1 FY27 Financial Results held on Thursday, November 05, 2026.

Q2FY27 Quarterly Result Announced for Sahajanand Medical Technologies Ltd.

<h3><span style="font-size:16px;"><strong>Healthcare Facilities company Sahajanand Medical Technologies announced Q2FY27 results</strong></span></h3> <p><strong _ngcontent-ng-c3650119362="">Consolidated Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Revenue from Operations:</strong> Stood at Rs 37,341.01 lakh in Q2FY27, growing 6.18% QoQ from Rs 35,166.85 lakh in Q1FY27 and increasing 24.69% YoY compared to Rs 29,947.09 lakh in Q2FY26.</li> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Other Income:</strong> Reported at Rs 223.58 lakh in Q2FY27, declining 16.04% QoQ from Rs 266.30 lakh in Q1FY27 and down 4.59% YoY compared to Rs 234.33 lakh in Q2FY26.</li> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Total Income:</strong> Stood at Rs 37,564.59 lakh in Q2FY27, reflecting an increase of 6.02% QoQ compared to Rs 35,433.15 lakh in Q1FY27 and a growth of 24.46% YoY from Rs 30,181.42 lakh in Q2FY26.</li> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Profit Before Tax (PBT):</strong> Rose to Rs 4,006.87 lakh in Q2FY27, up 64.99% QoQ from Rs 2,428.52 lakh in Q1FY27 and higher by 47.92% YoY compared to Rs 2,708.77 lakh in Q2FY26.</li> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Profit After Tax (PAT):</strong> Reached Rs 2,646.92 lakh in Q2FY27, registering a sharp growth of 75.38% QoQ compared to Rs 1,509.23 lakh in Q1FY27 and an increase of 26.60% YoY from Rs 2,090.77 lakh in Q2FY26.</li> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Net Profit Attributable to Owners of the Company:</strong> Stood at Rs 2,579.06 lakh in Q2FY27, up 77.00% QoQ from Rs 1,457.19 lakh in Q1FY27 and up 32.14% YoY from Rs 1,951.69 lakh in Q2FY26.</li> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Total Comprehensive Income:</strong> Reported at Rs 2,818.00 lakh in Q2FY27, surging 142.47% QoQ from Rs 1,162.22 lakh in Q1FY27, while decreasing 32.52% YoY compared to Rs 4,176.12 lakh in Q2FY26.</li> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Earnings Per Share (EPS):</strong> Basic EPS stood at Rs 2.63 per share in Q2FY27, up 77.70% QoQ compared to Rs 1.48 per share in Q1FY27 and up 31.50% YoY from Rs 2.00 per share in Q2FY26. Diluted EPS stood at Rs 2.56 per share in Q2FY27, up 76.55% QoQ from Rs 1.45 per share in Q1FY27 and up 31.96% YoY compared to Rs 1.94 per share in Q2FY26.</li> </ul> <p><strong _ngcontent-ng-c3650119362="">Standalone Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Revenue from Operations:</strong> Stood at Rs 15,858.23 lakh in Q2FY27, an increase of 3.38% QoQ compared to Rs 15,339.14 lakh in Q1FY27 and a growth of 17.50% YoY from Rs 13,496.20 lakh in Q2FY26.</li> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Other Income:</strong> Reported at Rs 194.71 lakh in Q2FY27, up 38.84% QoQ from Rs 140.24 lakh in Q1FY27 and up 12.73% YoY from Rs 172.72 lakh in Q2FY26.</li> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Total Income:</strong> Stood at Rs 16,052.94 lakh in Q2FY27, rising 3.71% QoQ compared to Rs 15,479.38 lakh in Q1FY27 and increasing 17.44% YoY compared to Rs 13,668.92 lakh in Q2FY26.</li> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Profit Before Tax (PBT):</strong> Came in at Rs 1,305.12 lakh in Q2FY27, marginally higher by 0.27% QoQ from Rs 1,301.66 lakh in Q1FY27, but lower by 15.16% YoY compared to Rs 1,538.28 lakh in Q2FY26.</li> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Profit After Tax (PAT):</strong> Reached Rs 983.05 lakh in Q2FY27, showing a growth of 5.47% QoQ from Rs 932.09 lakh in Q1FY27, and declining 19.46% YoY from Rs 1,220.64 lakh in Q2FY26.</li> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Total Comprehensive Income:</strong> Stood at Rs 983.05 lakh in Q2FY27, increasing 25.90% QoQ compared to Rs 780.84 lakh in Q1FY27, and declining 32.50% YoY compared to Rs 1,456.39 lakh in Q2FY26.</li> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Earnings Per Share (EPS):</strong> Basic EPS stood at Rs 1.00 per share in Q2FY27, up 5.26% QoQ from Rs 0.95 per share in Q1FY27, and down 20.63% YoY from Rs 1.26 per share in Q2FY26. Diluted EPS stood at Rs 0.98 per share in Q2FY27, up 5.38% QoQ from Rs 0.93 per share in Q1FY27, and down 19.67% YoY from Rs 1.22 per share in Q2FY26.</li> </ul> <p><strong _ngcontent-ng-c3650119362="">Business Highlights:</strong></p> <ul> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Segment Performance:</strong> The company and the group operate in a single reportable operating segment, "Cardiovascular Devices" (comprising Balloon Catheter, Cardiac Stents, TAVI, and Occluder), as evaluated by the Chief Operating Decision Maker (CODM) under Ind AS 108.</li> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">Strategic Investment / Acquisition:</strong> Approved an investment by Sahajanand Medical Technologies Ireland Limited (wholly owned subsidiary) to acquire additional stake in SNP Medical Corp., a US-based medical device startup registered in Delaware. SMT Ireland holds a 14.15% stake as of September 30, 2026, and with the proposed acquisition costing up to USD 7,80,000 in cash, its shareholding will increase up to 17.19%.</li> <li _ngcontent-ng-c3650119362=""><strong _ngcontent-ng-c3650119362="">IPO Listing:</strong> The company's equity shares were listed on BSE and NSE on October 23, 2026, following the completion of an Initial Public Offering (IPO) of 1,38,22,116 equity shares of face value of Re 1 each at an issue price of Rs 344 per equity share via an offer for sale.</li> </ul> <p><a class="lb" href="/get-document/post/pdf/5933939/" target="_blank">Result PDF</a></p>

Sahajanand Medical Technologies Financials

Sahajanand Medical Technologies Technicals

EMA & SMA

Current Price
₹533.95
+ 29.3 (5.81%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 5
  • 20 Day
  • -
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

523.32 Pivot Speed
  • R3 536.70
  • R2 527.80
  • R1 516.20
  • S1 495.80
  • S2 486.90
  • S3 475.30

Sahajanand Medical Technologies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-05 Quarterly Results

Sahajanand Medical Technologies Shareholding Pattern

36.2%
35.09%
13.42%
8.23%
3.59%

About Sahajanand Medical Technologies

Sahajanand Medical Technologies are a R&D-driven company engaged in the development of Class III and Class C/D medical devices, with an emphasis on Vascular Intervention (“VI”) and Structural Heart (“SH”). View More
  • NSE Symbol
  • SMT
  • BSE Symbol
  • 545001
  • Managing Director,Chief Executive Officer
  • BHARGAV DHIRAJLAL KOTADIA
  • ISIN
  • INE356Y01018

Similar Stocks to Sahajanand Medical Technologies

Sahajanand Medical Technologies FAQs

Sahajanand Medical Technologies share price is ₹533 As on 13 November, 2026 | 16:29

The Market Cap of Sahajanand Medical Technologies is ₹5427.4 Cr As on 13 November, 2026 | 16:29

The P/E ratio of Sahajanand Medical Technologies is As on 13 November, 2026 | 16:29

The PB ratio of Sahajanand Medical Technologies is 7.6 As on 13 November, 2026 | 16:29

The 52 week High & Low of Sahajanand Medical Technologies is ₹565.8/₹346.6 respectively As on 13 November, 2026 | 16:29

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23